Literature DB >> 24145631

Functional and visual improvement with prosthetic replacement of the ocular surface ecosystem scleral lenses for irregular corneas.

Jennifer C Lee1, Gloria B Chiu, Dianne Bach, Simon R Bababeygy, John Irvine, Martin Heur.   

Abstract

PURPOSE: To evaluate the Doheny Eye Institute Experience with Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lenses for the management of irregular corneas with outcomes based on visual acuity (VA) and visual function.
METHODS: A retrospective chart review of 58 subjects (90 eyes) with irregular corneal surfaces referred to the Doheny Eye Institute for PROSE treatment between July 2009 and December 2011 was performed. The best-corrected VA before and after PROSE fitting was recorded. A functional assessment before and after PROSE fitting was also performed using the Ocular Surface Disease Index, a 12-item questionnaire that grades the severity of ocular discomfort and vision-related function.
RESULTS: Keratoconus (43%) represented the largest group, and post-PK astigmatism (31%) represented the second largest group of patients with irregular corneas who had completed the PROSE treatment. Patients with keratoconus had the greatest improvement in VA after PROSE fitting with an 88% improvement in the logarithm of the minimal angle of resolution vision. Patients with post-PK astigmatism had the greatest improvement in Ocular Surface Disease Index scores with a 79% improvement observed after PROSE fitting.
CONCLUSIONS: PROSE scleral lenses offer improvements in the VA and function, and they could be an option for patients with irregular corneas who have failed conventional treatments before considering additional surgery.

Entities:  

Mesh:

Year:  2013        PMID: 24145631     DOI: 10.1097/ICO.0b013e3182a73802

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

1.  Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.

Authors:  Jia Yin; Deborah S Jacobs
Journal:  Ocul Surf       Date:  2018-11-20       Impact factor: 5.033

2.  Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens for Salzmann's nodular degeneration.

Authors:  Gloria B Chiu; Dianne Bach; Christos Theophanous; Martin Heur
Journal:  Saudi J Ophthalmol       Date:  2014-06-18

Review 3.  Limbal-Rigid Contact Lens Wear for the Treatment of Ocular Surface Disorders: A Review.

Authors:  Yulia Aziza; Motohiro Itoi; Mayumi Ueta; Tsutomu Inatomi; Shigeru Kinoshita; Chie Sotozono
Journal:  Eye Contact Lens       Date:  2022-07-08       Impact factor: 3.152

4.  Glaucoma Prevalence and Glaucoma Surgical Considerations in Prosthetic Replacement of the Ocular Surface Ecosystem Device Use.

Authors:  Andrew T Duong; Monica K Ertel; Sarah H Van Tassel
Journal:  Eye Contact Lens       Date:  2022-02-01       Impact factor: 2.018

Review 5.  Nonsurgical Procedures for Keratoconus Management.

Authors:  L Rico-Del-Viejo; M Garcia-Montero; J L Hernández-Verdejo; S García-Lázaro; F J Gómez-Sanz; A Lorente-Velázquez
Journal:  J Ophthalmol       Date:  2017-12-21       Impact factor: 1.909

Review 6.  Contact Lens-related Complications: A Review.

Authors:  Fateme Alipour; Saeed Khaheshi; Mahya Soleimanzadeh; Somayeh Heidarzadeh; Sepideh Heydarzadeh
Journal:  J Ophthalmic Vis Res       Date:  2017 Apr-Jun

Review 7.  Bifocal and Multifocal Contact Lenses for Presbyopia and Myopia Control.

Authors:  Laura Remón; Pablo Pérez-Merino; Rute J Macedo-de-Araújo; Ana I Amorim-de-Sousa; José M González-Méijome
Journal:  J Ophthalmol       Date:  2020-03-27       Impact factor: 1.909

8.  Large diameter scleral lens benefits for Asians with intractable ocular surface diseases: a prospective, single-arm clinical trial.

Authors:  Jayoon Moon; Sang-Mok Lee; Joon Young Hyon; Mee Kum Kim; Joo Youn Oh; Hyuk Jin Choi
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

9.  Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.

Authors:  Anna Cressey; Deborah S Jacobs; Crystal Remington; Karen G Carrasquillo
Journal:  Am J Ophthalmol Case Rep       Date:  2018-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.